This content is machine translated New oral therapy for ulcerative colitis Protected: First selective S1P receptor modulator in gastroenterology There is no excerpt because this is a protected post. CME-Test
View Post 13 min This content is machine translated Multiple sclerosis S1P receptor modulators in RRMS: tailored therapy management Modulation of S1P receptors is an important and interesting therapeutic target in the treatment management of multiple sclerosis due to their functional multifold. Currently, three S1P receptor modulators are available… CME-Test
View Post 1 min This content is machine translated Advanced training Launch event for interdisciplinary training on new treatment in ulcerative colitis On 01.09.2022 the interdisciplinary training on the treatment of ulcerative colitis incl. Discussion panel chaired by Prof. Dr. med. Dr. phil. Gerhard Rogler takes place. Registration for participation in the…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Pancreatic Cancer Module The Pancreatic Cancer module of Swiss Oncology in Motion includes articles by Prof. em. Richard Herrmann, MD, moderated presentations by Raphaël Delaloye, MD, (Department of Oncology, University Hospital Basel), PD… CME-Test
View Post 2 min This content is machine translated Virtual training series 2022: Dia-Month Club – the diamond among GP training courses on type 2 diabetes Type 2 diabetes – a condition that affects many patients in your family practice. But it is also a disease on which a great deal of research is still being…
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 1: Protecting the kidneys with the right therapy Modern diabetes management also protects the kidneys. In the live webinar on June 16, Prof. Roger Lehmann from the University Hospital Zurich used current study data to explain which therapies… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 2: Effectively supporting treatment adherence. Modern therapy for type 2 diabetes brings many benefits to patients – but only if it is followed. Doctor Bá Thanh-Trúc Ngô from Centramed Liestal showed in her live webinar… CME-Test
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2022) Module 3: Multifactorial therapy is the key Addressing all cardio-renal risk factors is worthwhile. In her live webinar on October 27, 2022, Prof. Isabella Sudano from the University Hospital Zurich showed how essential it is to effectively…
View Post 12 min This content is machine translated Axial spondyloarthritis and psoriatic arthritis Effective and efficient against pain The anti-IL-17A monoclonal antibody ixekizumab has already been approved since 2016 for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. In 2020, axial spondyloarthritis (axSpA) was added… CME-Test
View Post 11 min This content is machine translated Therapy of rheumatoid arthritis Long-term safety for RA patients under JAK inhibition The treatment of rheumatoid arthritis (RA) has made great progress over the past 20 years. This relates both to the range of drugs available and to developments in terms of… CME-Test
View Post 10 min This content is machine translated New AGLA guidelines Dyslipidemia – when to see a specialist? “The lower the better” – the approach to lower cholesterol levels as much as possible in patients at cardiovascular risk is more relevant than ever, according to the update of… CME-Test
